Knowledge Series
During these complimentary sessions, you’ll hear from our experienced team on a variety of forward-looking Medicare Secondary Payer (MSP) related topics with a focus on offering insights that help you stay informed and stay ahead – of both compliance requirements and your competition.
All webinars will be held on Wednesdays at 2:00 pm ET.
| March 22 | Can I Do Anything About My Result from CMS or am I Stuck? So, you submitted an MSA to CMS for review and received an unfavorable result, possibly impacting your settlement indefinitely. Are you stuck with their decision, or do you have options to pursue? Join us to explore the tools available for post-CMS review and how to set yourself up for success when requesting a Re-Review or Amended Review from CMS. Key takeaways:
|
|
| April 5 | Is It True That Non-Submit MSAs Can No Longer Be Used? In January of 2022, CMS released a new version of the WCMSA Reference Guide (version 3.5), adding section 4.3 The Use of Non-CMS-Approved Products to Address Future Medical Care. Some in the industry interpreted section 4.3 to mean you could no longer opt out of the CMS submission process. However, that is not the case. CMS followed with an updated version of the WCMSA Reference Guide, version 3.6, which confirmed that submission remains voluntary. We will walk through the facts and discuss where we stand on the age-old question – To Submit or Not Submit? Key takeaways:
|
|
| April 19 | Is CMS Still Approving Zero Waiver MSAs? In this webinar, we will explore considerations for Zero Waiver MSAs including examining the language and documentation required by CMS, discussing clean cases where no loss payments were made, and assessing the best methods for disputing Zero Waiver MSAs. Key takeaways:
|
Completed Webinars
Please email us for the password needed to access each recorded session.
| February 8 | What Do I Need to Know About Section 111 Reporting? Section 111 Reporting is a central part of Medicare Secondary Payer compliance. Mistakes in reporting ORM, ORM Termination, TPOC, ICD-Coding and other data can not only impact conditional lien exposure, but also may soon subject you, or your customers, to Civil Monetary Penalties. Key takeaways:
|
|
| February 22 | This Case Won’t be Able to Settle: How Can I Lower MSA Costs? Future settlement values are too often overinflated due to unclear documentation, inclusion of unwanted treatment(s), inclusion of high-dollar medications, and a variety of other reasons. We will discuss CMS’ policies, review claim mitigation strategies, and explore how to achieve mutually agreeable resolutions for you and the opposing party. We will provide several examples of ways to lower future medical projections and/or reduce the risks associated with the CMS submission process. Key takeaways:
|
|
| March 8 | Exploring Different Processes for Medicare Liens: Parts A, B, C, and D For traditional Medicare (Parts A and B), a specific process is used for conditional payment search and collections through Section 111 reporting information. However, the process may differ if a Medicare Part C or Part D plan is involved. Since Medicare has updated its query response system to include information from Medicare Part C and D plans, carrier/self-insureds now have a great opportunity to identify and resolve Medicare Part C and D liens prior to recovery litigation. Key takeaways:
|
Your Presenters
 |
Bridget Smith |
 |
Jennifer Shymanski |
 |
Jennifer Mislanovich |
 |
Mark Heberling |
 |
Patrick Czuprynski |
 |
Dawn Dietz |
Explore Our Blog
Beyond our knowledge series, our teammates regularly provide observations on the
latest industry news, offer analyses of CMS policy decisions, and deliver valuable
insights on MSP news while keeping our readers informed.